Objective 2


Production of biocompatible nanocolloids

 

The biosurfactants obtained from the consortium will be exploited in terms of their stabilities in nanocolloidal preparations. We will examine the ability of the pulmonary surfactant in the microfluidic production of bubbles with control on size and composition, with the aim of build up nanostructured materials as nanofoams easily transferred to nanomedicine applications. In particular, these systems will be used as biocompatible carriers of gases with biocompatibility properties. Additionally, we will analyze their properties as emulsion agents of the natural surfactant produced together with bacterial bioplastics. Considering the similar composition of the bacterial membrane, this material may be used to stabilize nanodroplets, and as a general concept, to stabilize different bacterial nanocavities, which will open up their uses as bacterial agent carriers.